| 1 |
Hosseini-hooshyar S, Hajarizadeh B, Bajis S, Law M, Janjua NZ, Fierer DS, Chromy D, Rockstroh JK, Martin TCS, Ingiliz P, Hung C, Dore GJ, Martinello M, Matthews GV. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression. The Lancet HIV 2022;9:e414-27. [DOI: 10.1016/s2352-3018(22)00077-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 2 |
Bischoff J, Mauss S, Lutz T, Cordes C, Klausen G, Scholten S, Hillenbrand H, Cornberg M, Baumgarten A, Rockstroh JK; German Hepatitis C-Registry. Late presentation of chronic hepatitis C patients in the era of direct-acting antivirals-Data from the German Hepatitis C-Registry. J Viral Hepat 2021;28:1660-4. [PMID: 34289197 DOI: 10.1111/jvh.13576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Falcato L, Bernardini C, Bruggmann P. Hepatitis C reinfection following successful direct-acting antiviral therapy among patients attending a multidisciplinary treatment centre for people who use drugs in Zurich, Switzerland. Int J Drug Policy 2021;96:103434. [PMID: 34511311 DOI: 10.1016/j.drugpo.2021.103434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Garvey LJ, Cooke GS, Smith C, Stingone C, Ghosh I, Dakshina S, Jain L, Waters LJ, Mahungu T, Ferro F, Sood C, Freeman C, Phillips C, Dhairyawan R, Burholt R, Sharp H, Ullah S, Gilleece Y, Brown A, Orkin C, Rodger A, Bhagani S. Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom? Clin Infect Dis 2021;72:233-8. [PMID: 32211763 DOI: 10.1093/cid/ciaa021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 5 |
Smit C, Boyd A, Rijnders BJA, van de Laar TJW, Leyten EM, Bierman WF, Brinkman K, Claassen MAA, den Hollander J, Boerekamps A, Newsum AM, Schinkel J, Prins M, Arends JE, Op de Coul ELM, van der Valk M, Reiss P; ATHENA observational cohort. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study. Lancet HIV. 2021;8:e96-e105. [PMID: 33357835 DOI: 10.1016/s2352-3018(20)30301-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 6 |
. Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases consensus panel. AIDS 2020;34:1699-711. [PMID: 32694411 DOI: 10.1097/QAD.0000000000002622] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 7 |
Nijmeijer BM, Koopsen J, Schinkel J, Prins M, Geijtenbeek TB. Sexually transmitted hepatitis C virus infections: current trends, and recent advances in understanding the spread in men who have sex with men. J Int AIDS Soc 2019;22 Suppl 6:e25348. [PMID: 31468692 DOI: 10.1002/jia2.25348] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 8 |
Bradshaw D, Vasylyeva TI, Davis C, Pybus OG, Thézé J, Thomson EC, Martinello M, Matthews GV, Burholt R, Gilleece Y, Cooke GS, Page EE, Waters L, Nelson M. Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in England. J Viral Hepat 2020;27:721-30. [PMID: 32115809 DOI: 10.1111/jvh.13286] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 9 |
Mattingly TJ 2nd. Elimination of Hepatitis C Virus Infection in Canada-It Is Achievable, But Is the Rest of the World Ready to Join in the Effort? JAMA Netw Open 2020;3:e204355. [PMID: 32374394 DOI: 10.1001/jamanetworkopen.2020.4355] [Reference Citation Analysis]
|
| 10 |
Macgregor L, Desai M, Martin NK, Nicholls J, Hickson F, Weatherburn P, Hickman M, Vickerman P. Scaling up screening and treatment for elimination of hepatitis C among men who have sex with men in the era of HIV pre-exposure prophylaxis. EClinicalMedicine 2020;19:100217. [PMID: 32140664 DOI: 10.1016/j.eclinm.2019.11.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Ghany MG, Morgan TR; AASLD-IDSA Hepatitis C Guidance Panel. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology 2020;71:686-721. [PMID: 31816111 DOI: 10.1002/hep.31060] [Cited by in Crossref: 348] [Cited by in F6Publishing: 357] [Article Influence: 116.0] [Reference Citation Analysis]
|
| 12 |
Gaska JM, Balev M, Ding Q, Heller B, Ploss A. Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus. Elife 2019;8:e44436. [PMID: 31074414 DOI: 10.7554/eLife.44436] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
|
